Tag Archives | Abbott Laboratories

Fair Treatment of Shareholder Nominees Progress & Holdouts

Fair Treatment of Shareholder Nominees: Progress & Holdouts

As indicated previously (ABT: Fair Treatment of Shareholder Nominees), James McRitchie filed several proposals this season to ensure that universal proxies do not go the same route as proxy access, which became worthless when most companies limited groups of nominating shareholders to 20. Together with The Shareholder Commons, we are trying to prevent universal proxy […]

Continue Reading · 1
ABT Fair Treatment of Shareholder Nominees cover of 2023 proxy

ABT: Fair Treatment of Shareholder Nominees

ABT Fair Treatment of Shareholder Nominees is an update of my (James McRitchie) effort in the recent proxy season to address the growth of abusive advance notice bylaws aimed at disadvantaging shareholder nominees under universal proxy rules. (see Procter & Gamble Fair Elections and Procter & Gamble 2023: Our Proxy Votes, which won 43% of […]

Continue Reading ·
Virtual Meeting Problems Highlighted by CII

Virtual Meeting Problems Highlighted by CII

Virtual meeting problems were highlighted in this excerpt from CII’s Weekly Governance Alert Vol 25, Issue 17 | April 30, 2020 by Rosemary Lally. I am reproducing below in order to ensure it gets wider distribution. Virtual meetings, in my experience, have been more problematic when hosted by Computershare than Broadridge but I have had […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes